V. Silani

Cerebral Amyloid Angiopathy-Related Inflammation: An Emerging Disease

A. Falini, A. Erbetta, S. Messina, 2011, The neuroradiology journal.

Mutations in the tail domain of the neurofilament heavy chain gene increase the risk of amyotrophic lateral sclerosis

A. Al-Chalabi, J. Glass, J. Landers, 2022, medRxiv.

Large-scale analyses of CAV1 and CAV2 suggest their expression is higher in post-mortem ALS brain tissue and affects survival

Ashley R. Jones, G. Breen, A. Al-Chalabi, 2022, Frontiers in Cellular Neuroscience.

Mutational analysis reveals the FUS homolog TAF15 as a candidate gene for familial amyotrophic lateral sclerosis

Robert H. Brown, D. A. Bosco, C. Shaw, 2011, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

28. Treatment with onabotulinumtoxinA of pectoral spasm after expander-based breast reconstruction

L. Maderna, A. Doretti, S. Gerevini, 2016, Clinical Neurophysiology.

Low brain‐derived neurotrophic factor (BDNF) levels in serum of Huntington's disease patients

S. Calza, L. Frati, F. Squitieri, 2007, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

Unsupervised machine-learning identifies clinically distinct subtypes of ALS that reflect different genetic architectures and biological mechanisms

Ahmad Al Khleifat, A. Al-Chalabi, P. Andersen, 2023, medRxiv.

Increased Il-8 Levels in the Cerebrospinal Fluid of Patients with Amyotrophic Lateral Sclerosis

E. Beghi, P. Ghezzi, L. Giordano, 2009 .